JANX vs BIIB: Which Stock is Better?
Side-by-side comparison of Janux Therapeutics Inc and Biogen Inc in 2026
JANX
Janux Therapeutics Inc
$15.24
BIIB
Biogen Inc
$178.96
Key Metrics Comparison
| Metric | JANX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $906.39M | $25.88B | BIIB |
| P/E Ratio | N/A | 20.09 | BIIB |
| EPS (TTM) | $N/A | $8.78 | BIIB |
| Revenue Growth | 21.8% | -0.1% | JANX |
| Gross Margin | -1159.0% | 78.9% | BIIB |
Analyze JANX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is JANX or BIIB a better investment?
Comparing JANX and BIIB: Janux Therapeutics Inc has a market cap of $906.39M while Biogen Inc has $25.88B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between JANX and BIIB?
JANX (Janux Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: JANX or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: JANX or BIIB?
JANX has higher revenue growth at 21.8% vs -0.1% for BIIB.
Which company is more profitable: JANX or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -1159.0% for JANX.
Which is the larger company: JANX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $25.88B compared to $906.39M for JANX.
Should I buy JANX or BIIB in 2026?
Both JANX and BIIB have investment merit. JANX trades at $15.24 while BIIB trades at $178.96. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between JANX and BIIB stock?
Key differences: Market Cap ($906.39M vs $25.88B), P/E Ratio (N/A vs 20.1x), Revenue Growth (21.8% vs -0.1%), Gross Margin (-1159.0% vs 78.9%).